A rare fungus that eats into the brain has quadrupled its detection rate in just two years, and the Centers for Disease Control and Prevention (CDC) admits it does not know why.
Quick Take
- CDC found 49 cases of Cladophialophora bantiana, a brain-attacking mold, between 2009 and mid-2026.
- Detections jumped fourfold from 2023 to 2025, rising from single digits to 14 cases in one year.
- Nearly 9 in 10 infections struck the brain and central nervous system, with a median patient age of 68.
- Cases turned up in 21 states and Washington, D.C., with no clear outbreak source identified.
- Health officials relied on just one lab for this data, raising questions about America’s disease-tracking system.
Fourfold Jump in Detections Raises Alarm
The CDC published its findings October 2 in the agency’s Morbidity and Mortality Weekly Report. Researchers tracked a soil-dwelling mold called Cladophialophora bantiana using broad-range fungal testing at a clinical reference laboratory. The data showed detections per 1,000 submitted brain-tissue specimens rose roughly fourfold from 2023 to 2025. Annual case counts that hovered between one and five for over a decade jumped to eight in 2024, then 14 in 2025.
In total, the CDC identified 48 confirmed cases and one probable case stretching back to 2009. That is a small number spread over 17 years, but the recent spike is what caught investigators’ attention. The agency adjusted for how many specimens were actually tested, so the rise is not simply explained by doctors ordering more tests.
Brain Infections Dominate the Case Count
This is not a mild bug. Of the 49 cases identified, 43 — or 88% — involved direct infection of brain tissue. The remaining six cases were found in the lungs. Outside research has long documented that this fungus carries a mortality rate near 70%, regardless of a patient’s immune status, making it one of the deadliest organisms doctors rarely talk about.
The typical patient was older, with a median age of 68 and an age range mostly between 63 and 74. That detail matters for families watching aging parents or grandparents, since older Americans with weaker immune defenses may face greater risk from an infection doctors still struggle to catch early or treat effectively.
Cases Spread Across the Country With No Clear Source
This is not a localized outbreak tied to one hospital or city. The CDC traced cases to 21 states and the District of Columbia. California logged six cases, Florida and Texas five each, and Pennsylvania four. That spread suggests exposure is happening somewhere ordinary Americans encounter dirt, dust, or decaying organic material, though officials have not pinpointed an exact source.
Scientists still do not know how people pick up this infection. No confirmed environmental reservoir or transmission route has been established, despite the fungus being first identified decades ago. That gap leaves a real public-health question unanswered while case numbers climb.
Health Officials Admit They Don’t Know Why
CDC’s own report leans on detections from a single reference laboratory tied to the University of Washington, not a nationwide surveillance network. That is a notable limitation for an agency that spent years during COVID demanding Americans trust centralized, top-down health data. When the government’s own disease trackers depend on one lab’s caseload, taxpayers deserve to ask why broader surveillance does not already exist.
CDC field investigation guidance itself warns that apparent disease spikes can sometimes reflect more testing or better awareness rather than a true rise in infections, not a different organism spreading faster. Separating real outbreaks from testing artifacts matters, and the agency has not yet determined which explanation fits this fungus.
What is established is serious enough on its own: a dangerous, hard-to-treat fungus is showing up more often, hitting the brain in the vast majority of cases, and striking older Americans across a wide swath of the country. Families, especially those caring for elderly relatives, should take note while federal health officials work to explain the cause and scope of this trend.
The bigger lesson may be about government readiness. Years of bureaucratic bloat and shifting health priorities under past administrations left basic disease surveillance thin in spots, even as agencies pushed sweeping mandates on healthy Americans. A rare fungus slipping past a patchwork tracking system is a reminder that real public-health investment belongs in detection and transparency, not political overreach.
Sources:
insiderpaper.com, cdc.gov, ai.meta.com, biz.heraldcorp.com
